Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 6/20 | 0.65 |
| ▸ | TAS1R1 | Q7RTX1 | 6/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.60 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | RECQL | P46063 | 1/20 | 0.55 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.52 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.52 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.52 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.52 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.51 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.51 |
| ▸ | CDC25B | P30305 | 1/20 | 0.51 |
| ▸ | GSK3B | P49841 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.49 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.49 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.49 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6720404 | 1.00 | TAS1R3 (0.65) | TAS1R3TAS1R1SMN1; SMN2GAARECQL | |
| SCHEMBL4164500 | 0.88 | TAS1R3 (0.82) | TAS1R3TAS1R1SMN1; SMN2GAARECQL | |
| SCHEMBL5546193 | 0.85 | GRIA1 (0.52) | TAS1R3TAS1R1HDAC3HDAC1HDAC2 | |
| SCHEMBL6694863 | 0.85 | NOS2 (0.51) | TAS1R3TAS1R1HDAC3HDAC1HDAC2 | |
| SCHEMBL6713032 | 0.85 | NOS2 (0.51) | TAS1R3TAS1R1HDAC3HDAC1HDAC2 | |
| SCHEMBL6694861 | 0.85 | NOS2 (0.51) | TAS1R3TAS1R1HDAC3HDAC1HDAC2 | |
| SCHEMBL28977231 | 0.85 | NOS2 (0.51) | TAS1R3TAS1R1HDAC3HDAC1HDAC2 | |
| SCHEMBL31611839 | 0.84 | SMN1; SMN2 (0.64) | TAS1R3TAS1R1SMN1; SMN2GAARECQL | |
| SCHEMBL31452779 | 0.84 | TAS1R3 (0.59) | TAS1R3TAS1R1SMN1; SMN2GAARECQL | |
| SCHEMBL4599812 | 0.83 | FPR2 (0.56) | TAS1R3TAS1R1SMN1; SMN2HDAC3HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040048928-A1 | Novel amino acid compounds and photoprotecting compositions comprised thereof | L'OREAL (FR) | 2004-03-11 | — | — | US | claimed |
| EP-1278718-B1 | NOVEL AMINO ACID DERIVATIVES, PREPARATION METHOD, COMPOSITIONS CONTAINING SAME AND USES THEREOF AS SUNSCREENS | OREAL (FR) | 2003-12-17 | — | — | EP | claimed |
| US-6641802-B2 | Copper sulfat complexes to amino acid | SOCIETE L'OREAL S.A. (FR) | 2003-11-04 | — | — | US | claimed |
| EP-1278718-A1 | NOVEL AMINO ACID DERIVATIVES, PREPARATION METHOD, COMPOSITIONS CONTAINING SAME AND USES THEREOF AS SUNSCREENS | L'OREAL (FR) | 2003-01-29 | — | — | EP | claimed |
| US-20020150545-A1 | Novel amino acid compounds and photoprotecting compositions comprised thereof | L'OREAL (FR) | 2002-10-17 | — | — | US | claimed |
| WO-2001081297-A1 | NOVEL AMINO ACID DERIVATIVES, PREPARATION METHOD, COMPOSITIONS CONTAINING SAME AND USES THEREOF AS SUNSCREENS | L'OREAL (FR) | 2001-11-01 | — | — | WO | claimed |
| US-20040048928-A1 | Novel amino acid compounds and photoprotecting compositions comprised thereof | L'OREAL (FR) | 2004-03-11 | — | — | US | disclosed |
| EP-1278718-B1 | NOVEL AMINO ACID DERIVATIVES, PREPARATION METHOD, COMPOSITIONS CONTAINING SAME AND USES THEREOF AS SUNSCREENS | OREAL (FR) | 2003-12-17 | — | — | EP | disclosed |
| US-6641802-B2 | Copper sulfat complexes to amino acid | SOCIETE L'OREAL S.A. (FR) | 2003-11-04 | — | — | US | disclosed |
| EP-1278718-A1 | NOVEL AMINO ACID DERIVATIVES, PREPARATION METHOD, COMPOSITIONS CONTAINING SAME AND USES THEREOF AS SUNSCREENS | L'OREAL (FR) | 2003-01-29 | — | — | EP | disclosed |
| US-20020150545-A1 | Novel amino acid compounds and photoprotecting compositions comprised thereof | L'OREAL (FR) | 2002-10-17 | — | — | US | disclosed |
| WO-2001081297-A1 | NOVEL AMINO ACID DERIVATIVES, PREPARATION METHOD, COMPOSITIONS CONTAINING SAME AND USES THEREOF AS SUNSCREENS | L'OREAL (FR) | 2001-11-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020150545-A1 | Novel amino acid compounds and photoprotecting compositions comprised thereof | PELP1, ALAD, CRY1 | TAS1R3 2949/4885TAS1R1 1761/4885SMN1; SMN2 4490/4885 |
| US-20040048928-A1 | Novel amino acid compounds and photoprotecting compositions comprised thereof | PELP1, ALAD, CRY1 | TAS1R3 2949/4885TAS1R1 1761/4885SMN1; SMN2 4490/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.